GOLDENWELL BIOTECH, INC. (GWLL)
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Hudson, Ohio.
Sector: Food and Kindred Products
Industry: Medical - Pharmaceuticals
Goldenwell Biotech, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 99.00M shares outstanding
USGoldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States.
It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement.
The company was incorporated in 2019 and is based in Hudson, Ohio.
Leadership
Hua Xie
Secretary & Director
Li Yang
Treasurer & Director
Shuang Liu
Chairman, Chief Executive Officer & President
Employees
3
Country
US
Sector
Healthcare
Website
goldenwellbiotech.com
| Name | Shares | % | Source |
|---|---|---|---|
Ming Zhou · may incl. warrants· filed Oct 2026 | 20.0M | 20.2% | 13D |
based on 99.00M shares outstanding
US30d Avg
344
60d Avg
514
90d Avg
589